United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 2, 2026 · Filed Jun 3, 2026

On Jun 2, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$538.40 for US$5.11M under a trading plan, leaving 40,513 shares. Filed Jun 3, 2026 (Form 4).

Sold
9,500 shares
Price
US$538.40 average (US$535.69 to US$543.26)
Value
US$5.11M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 2, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 2, 2026Common StockSale1,160US$535.6948,853Direct
Jun 2, 2026Common StockSale2,056US$536.6246,797Direct
Jun 2, 2026Common StockSale1,464US$537.6245,333Direct
Jun 2, 2026Common StockSale1,149US$538.8144,184Direct
Jun 2, 2026Common StockSale2,310US$539.8341,874Direct
Jun 2, 2026Common StockSale641US$540.4841,233Direct
Jun 2, 2026Common StockSale440US$541.6840,793Direct
Jun 2, 2026Common StockSale280US$543.2640,513Direct

Source

View original at SEC

Related